Rhizopus oryzae (Nelco Laboratories, Inc.)
Welcome to the PulseAid listing for the Rhizopus oryzae drug offered from Nelco Laboratories, Inc.. This Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Nelco Laboratories, Inc. |
| NON-PROPRIETARY NAME: | Rhizopus oryzae |
| SUBSTANCE NAME: | RHIZOPUS ARRHIZUS VAR. ARRHIZUS |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient] |
| ROUTE: | INTRADERMAL; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1972-08-29 |
| END MARKETING DATE: | 0000-00-00 |
Rhizopus oryzae HUMAN PRESCRIPTION DRUG Details:
| Item Description | Rhizopus oryzae from Nelco Laboratories, Inc. |
| LABELER NAME: | Nelco Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10000([PNU]/mL) |
| START MARKETING DATE: | 1972-08-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 36987-2073_42de87a6-4ad2-4dd1-ae19-915aec27f42c |
| PRODUCT NDC: | 36987-2073 |
| APPLICATION NUMBER: | BLA102192 |
Other RHIZOPUS ARRHIZUS VAR. ARRHIZUS Pharmaceutical Manufacturers / Labelers:
